Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (311-320 of 457) with videos related to

Pageof 46
Sort By:
Haematologica|July 17, 2025
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatmentOudai Alkabbani, Yazan Jabban, Rong He, et al.
Ejhaem|December 17, 2025
Blast Clearance Dynamics and Time to Response Across <i>IDH1-</i> and <i>IDH2</i>-Mutated AMLMohamad Sheikh Najeeb, Oudai Alkabbani, Rong He, et al.
American Journal of Hematology|October 30, 2018
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult diseaseMark R Litzow, Xin V Wang, Martin P Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
American Journal of Hematology|November 20, 2022
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patientsAbhishek A Mangaonkar, Kimberly J Langer, Terra L Lasho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
European Journal of Haematology|January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeAngela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Haematologica|February 10, 2022
<i>SF3B1</i>-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entityAbhishek A Mangaonkar, Terra L Lasho, Christy Finke, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' <i>versus</i> 'single-hit' <i>TP53</i> alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary FunctionsMehrdad Hefazi, Kimberly J Langer, Nandita Khera, et al.
Pageof 46

Showing results (311-320 of 457) with videos related to

Sort By:
Pageof 46
Haematologica|July 17, 2025
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatmentOudai Alkabbani, Yazan Jabban, Rong He, et al.
Ejhaem|December 17, 2025
Blast Clearance Dynamics and Time to Response Across <i>IDH1-</i> and <i>IDH2</i>-Mutated AMLMohamad Sheikh Najeeb, Oudai Alkabbani, Rong He, et al.
American Journal of Hematology|October 30, 2018
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult diseaseMark R Litzow, Xin V Wang, Martin P Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
American Journal of Hematology|November 20, 2022
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patientsAbhishek A Mangaonkar, Kimberly J Langer, Terra L Lasho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
European Journal of Haematology|January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeAngela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Haematologica|February 10, 2022
<i>SF3B1</i>-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entityAbhishek A Mangaonkar, Terra L Lasho, Christy Finke, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' <i>versus</i> 'single-hit' <i>TP53</i> alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary FunctionsMehrdad Hefazi, Kimberly J Langer, Nandita Khera, et al.
Pageof 46